Laurie Villanueva

Laurie Villanueva has been writing about consumer issues for over two decades, Her work for largely focuses on pharmaceutical and medical device safety, including the ongoing litigation surrounding Risperdal, proton pump inhibitors, Invokana, Levaquin, defective hip implants, the Bair Hugger forced air warming blanket, and IVC filters. Laurie has also devoted a great deal of coverage to women’s health issues, especially recent litigation involving talcum powder, power morcellators, transvaginal mesh, and breast implants.

Laurie graduated from Penn State University in 1990 with a degree in journalism. After spending many years covering local government for various print media outlets, she is now focused on utilizing the internet to raise awareness about important consumer issues.

Onglyza Lawsuit Court Issues Order Governing Plaintiff Profile Forms

The federal court overseeing coordinated pretrial proceedings for hundreds of Onglyza lawsuits has issued its second Case Management Order, which governs the production of Plaintiff Profile Forms. There are currently 226 Onglyza lawsuits pending in the U.S. District Court, Eastern … Continue reading

Glyphosate Cancer Concerns Prompt French Court to Pull License for Monsanto Roundup Product

A French court has canceled Bayer’s license for Monsanto Roundup Pro 360, one of its glyphosate-based herbicides. In doing so, the Lyon court found that the country’s environmental regulator failed to consider its product’s health risks when it approved the … Continue reading

Valsartan Lawsuits Mount, With Filing of Bladder Cancer Claim in Louisiana Federal Court

Lawsuits stemming from ongoing valsartan recalls continue to mount in courts throughout the United States. One of the most recent valsartan lawsuits was filed by a Louisiana man who claims his use of recalled drugs were the direct cause of his … Continue reading

Torrent Pharmaceuticals Expands Blood Pressure Drug Recall for Contaminated Losartan Tablets

Torrent Pharmaceuticals has expanded its blood pressure drug recall to include eight additional lots of generic losartan tablets. What to Know the Torrent Blood Pressure Drug Recall According to the company, the losartan tablets could be contaminated with N-nitrosodiethylamine (NDEA), … Continue reading

OptiMark MRI Contrast Dye Lawsuit Transferred to New Jersey Federal Court

An MRI contrast dye lawsuit involving OptiMark will be litigated in New Jersey, after a federal judge determined that the jurisdiction has the most significant relationship to the case. According to a complaint originally filed in the U.S. District Court, … Continue reading

Johnson & Johnson Prepping for More Talcum Powder Lawsuit Trials in 2019

The new year could prove pivotal for Johnson & Johnson, as the company faces numerous trials involving the alleged link between its popular talcum powder products and cancer. In fact, jury selection for a mesothelioma case is set to begin … Continue reading

Plaintiffs in Federal Truvada Lawsuits, Other Gilead TDF HIV Drug Claims Request Centralization

Plaintiffs pursuing lawsuits against Gilead Sciences, Inc. over toxic side effects allegedly caused by Truvada and similar HIV drugs want their cases centralized in a single federal court. 5 TDF HIV Drug Lawsuits Filed on Behalf of 150 Plaintiffs According … Continue reading

Opioid Lawsuit News: Former Insys CEO to Admit Guilt in Subsys Spray Kickback Case

The former CEO of Insys, Inc. will admit to his role in a kickback scheme involving Subsys Spray, an under-the-tongue version of a powerful opioid called fentanyl. According to a January 2nd filing in the U.S. District Court, District of … Continue reading

Illinois Appeals Court Denies Merck’s Motion to Dismiss Januvia Pancreatic Cancer Lawsuit

An Illinois appeals court has denied Merck & Co.’s motion to dismiss a lawsuit involving Januvia and pancreatic cancer. According to, the lawsuit was filed in Cook County Circuit Court by the survivors of four Januvia patients who died … Continue reading

Johnson & Johnson Reaches $1.5 Million Talcum Powder Settlement in New York Asbestos Case

Johnson & Johnson has agreed to pay $1.5 million to a New York woman who says her long-term use of Baby Powder caused a deadly form of cancer. New York Judge Warned Plaintiff Could be Entitled to Punitive Damages According … Continue reading

Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest